Benzodiazepine Use among Depressed Patients Treated in Mental Health Settings

Marcia Valenstein, Kiran Khanujua Taylor, Karen Austin, Helen C. Kales, John F. McCarthy, Frederic C. Blow

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Objective: Most depression treatment guidelines emphasize treatment with antidepressant medication and recommend that benzodiazepine use be minimized, particularly among elderly patients. However, little is known about patterns of benzodiazepine use in specialty mental health settings. The authors examined benzodiazepine use among a large sample of depressed patients treated in U.S. Department of Veterans Affairs (VA) mental health settings. Method: The VA National Registry for Depression was used to identify patients treated for depression in specialty mental health settings in 129 VA facilities during the first 3 months of fiscal year 2001 (October 1 to December 31, 2000) (N= 128,029). The VA pharmacy database was used to identify outpatients who filled a prescription for benzodiazepines. The authors report on the prevalence and patterns of outpatient benzodiazepine use during the study year (fiscal year 2001) and evaluate patient demographic and clinical factors associated with use. Results: During the study year, 36% of the depressed patients filled a benzodiazepine prescription and 89% filled an antidepressant prescription. Most users (78%) received ≥90 days' supply of benzodiazepines, and 61% received ≥180 days' supply. Older patients, whites, Hispanics, and patients with comorbid anxiety disorders were more likely to use benzodiazepines. Older patients were also more likely to receive ≥90 days' supply of benzodiazepines, compared with younger patients, but were treated with lower doses. Benzodiazepine use varied significantly with region of the country and facility. Conclusions: Depressed patients treated in mental health settings commonly receive long-term treatment with benzodiazepines in combination with antidepressants, a pattern of use that is inconsistent with guideline recommendations. Elderly patients are particularly likely to receive benzodiazepines. Further research on the effectiveness of this widespread practice is needed.

Original languageEnglish (US)
Pages (from-to)654-661
Number of pages8
JournalAmerican Journal of Psychiatry
Volume161
Issue number4
DOIs
StatePublished - Apr 1 2004
Externally publishedYes

Fingerprint

Benzodiazepines
Mental Health
Veterans
Antidepressive Agents
Prescriptions
Depression
Outpatients
Guidelines
United States Department of Veterans Affairs
Anxiety Disorders
Hispanic Americans
Registries
Therapeutics
Demography
Databases

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Benzodiazepine Use among Depressed Patients Treated in Mental Health Settings. / Valenstein, Marcia; Taylor, Kiran Khanujua; Austin, Karen; Kales, Helen C.; McCarthy, John F.; Blow, Frederic C.

In: American Journal of Psychiatry, Vol. 161, No. 4, 01.04.2004, p. 654-661.

Research output: Contribution to journalArticle

Valenstein, Marcia ; Taylor, Kiran Khanujua ; Austin, Karen ; Kales, Helen C. ; McCarthy, John F. ; Blow, Frederic C. / Benzodiazepine Use among Depressed Patients Treated in Mental Health Settings. In: American Journal of Psychiatry. 2004 ; Vol. 161, No. 4. pp. 654-661.
@article{282076ea575841d6aae710a696bc5adf,
title = "Benzodiazepine Use among Depressed Patients Treated in Mental Health Settings",
abstract = "Objective: Most depression treatment guidelines emphasize treatment with antidepressant medication and recommend that benzodiazepine use be minimized, particularly among elderly patients. However, little is known about patterns of benzodiazepine use in specialty mental health settings. The authors examined benzodiazepine use among a large sample of depressed patients treated in U.S. Department of Veterans Affairs (VA) mental health settings. Method: The VA National Registry for Depression was used to identify patients treated for depression in specialty mental health settings in 129 VA facilities during the first 3 months of fiscal year 2001 (October 1 to December 31, 2000) (N= 128,029). The VA pharmacy database was used to identify outpatients who filled a prescription for benzodiazepines. The authors report on the prevalence and patterns of outpatient benzodiazepine use during the study year (fiscal year 2001) and evaluate patient demographic and clinical factors associated with use. Results: During the study year, 36{\%} of the depressed patients filled a benzodiazepine prescription and 89{\%} filled an antidepressant prescription. Most users (78{\%}) received ≥90 days' supply of benzodiazepines, and 61{\%} received ≥180 days' supply. Older patients, whites, Hispanics, and patients with comorbid anxiety disorders were more likely to use benzodiazepines. Older patients were also more likely to receive ≥90 days' supply of benzodiazepines, compared with younger patients, but were treated with lower doses. Benzodiazepine use varied significantly with region of the country and facility. Conclusions: Depressed patients treated in mental health settings commonly receive long-term treatment with benzodiazepines in combination with antidepressants, a pattern of use that is inconsistent with guideline recommendations. Elderly patients are particularly likely to receive benzodiazepines. Further research on the effectiveness of this widespread practice is needed.",
author = "Marcia Valenstein and Taylor, {Kiran Khanujua} and Karen Austin and Kales, {Helen C.} and McCarthy, {John F.} and Blow, {Frederic C.}",
year = "2004",
month = "4",
day = "1",
doi = "10.1176/appi.ajp.161.4.654",
language = "English (US)",
volume = "161",
pages = "654--661",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "4",

}

TY - JOUR

T1 - Benzodiazepine Use among Depressed Patients Treated in Mental Health Settings

AU - Valenstein, Marcia

AU - Taylor, Kiran Khanujua

AU - Austin, Karen

AU - Kales, Helen C.

AU - McCarthy, John F.

AU - Blow, Frederic C.

PY - 2004/4/1

Y1 - 2004/4/1

N2 - Objective: Most depression treatment guidelines emphasize treatment with antidepressant medication and recommend that benzodiazepine use be minimized, particularly among elderly patients. However, little is known about patterns of benzodiazepine use in specialty mental health settings. The authors examined benzodiazepine use among a large sample of depressed patients treated in U.S. Department of Veterans Affairs (VA) mental health settings. Method: The VA National Registry for Depression was used to identify patients treated for depression in specialty mental health settings in 129 VA facilities during the first 3 months of fiscal year 2001 (October 1 to December 31, 2000) (N= 128,029). The VA pharmacy database was used to identify outpatients who filled a prescription for benzodiazepines. The authors report on the prevalence and patterns of outpatient benzodiazepine use during the study year (fiscal year 2001) and evaluate patient demographic and clinical factors associated with use. Results: During the study year, 36% of the depressed patients filled a benzodiazepine prescription and 89% filled an antidepressant prescription. Most users (78%) received ≥90 days' supply of benzodiazepines, and 61% received ≥180 days' supply. Older patients, whites, Hispanics, and patients with comorbid anxiety disorders were more likely to use benzodiazepines. Older patients were also more likely to receive ≥90 days' supply of benzodiazepines, compared with younger patients, but were treated with lower doses. Benzodiazepine use varied significantly with region of the country and facility. Conclusions: Depressed patients treated in mental health settings commonly receive long-term treatment with benzodiazepines in combination with antidepressants, a pattern of use that is inconsistent with guideline recommendations. Elderly patients are particularly likely to receive benzodiazepines. Further research on the effectiveness of this widespread practice is needed.

AB - Objective: Most depression treatment guidelines emphasize treatment with antidepressant medication and recommend that benzodiazepine use be minimized, particularly among elderly patients. However, little is known about patterns of benzodiazepine use in specialty mental health settings. The authors examined benzodiazepine use among a large sample of depressed patients treated in U.S. Department of Veterans Affairs (VA) mental health settings. Method: The VA National Registry for Depression was used to identify patients treated for depression in specialty mental health settings in 129 VA facilities during the first 3 months of fiscal year 2001 (October 1 to December 31, 2000) (N= 128,029). The VA pharmacy database was used to identify outpatients who filled a prescription for benzodiazepines. The authors report on the prevalence and patterns of outpatient benzodiazepine use during the study year (fiscal year 2001) and evaluate patient demographic and clinical factors associated with use. Results: During the study year, 36% of the depressed patients filled a benzodiazepine prescription and 89% filled an antidepressant prescription. Most users (78%) received ≥90 days' supply of benzodiazepines, and 61% received ≥180 days' supply. Older patients, whites, Hispanics, and patients with comorbid anxiety disorders were more likely to use benzodiazepines. Older patients were also more likely to receive ≥90 days' supply of benzodiazepines, compared with younger patients, but were treated with lower doses. Benzodiazepine use varied significantly with region of the country and facility. Conclusions: Depressed patients treated in mental health settings commonly receive long-term treatment with benzodiazepines in combination with antidepressants, a pattern of use that is inconsistent with guideline recommendations. Elderly patients are particularly likely to receive benzodiazepines. Further research on the effectiveness of this widespread practice is needed.

UR - http://www.scopus.com/inward/record.url?scp=1842585686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842585686&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.161.4.654

DO - 10.1176/appi.ajp.161.4.654

M3 - Article

C2 - 15056511

AN - SCOPUS:1842585686

VL - 161

SP - 654

EP - 661

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 4

ER -